Innovations In Cardiovascular Medicine & Surgery | Fall 2018
Showing of 6 results
LimFlow Offers Hope for No Option CLI Patients
Minimally invasive technique provides endovascular venous arterialization Innovations in Cardiovascular Medicine & Surgery – Fall 2018 Mehdi H. Shishehbor, DO, PhD, MPH A breakthrough First in Man (FIM) clinical trial within the Harrington Heart &...
HIV and Cardiovascular Disease Does It Manifest Differently in Sub:Saharan Africa?
UH researcher reports on first study in this population to use calcium scoring, will probe role of latent TB infection Innovations in Cardiovascular Medicine & Surgery - Fall 2018 Christopher Longenecker, MD Do people living with HIV in...
Clinical Trial at UH Seeks to Improve Outcomes for TAVR Patients
Two anti-platelet drugs studied for their effect on platelet function and immune activation post-procedure Innovations in Cardiovascular Medicine & Surgery - Fall 2018 David A. Zidar, MD, PhD Transcatheter aortic valve replacement (TAVR) has...
MAGMA and EXHALTED Trials Seek Ways to Monitor Disease Progression and Improve Outcomes
Trials employ novel imaging technologies for high-risk cases Innovations in Cardiovascular Medicine & Surgery - Fall 2018 Sanjay Rajagopalan, MD Mirela Dobre, MD, MPH Physicians of the Harrington Heart & Vascular Institute at University...
UH is First Hospital System in the Nation to Earn Coveted ACC Chest Pain Center Version 6 Accreditation
The highest quality in treating chest pain Innovations in Cardiovascular Medicine & Surgery – Fall 2018 Mehdi Shishehbor, DO, MPH, PhD In May 2018, a seven-months-long process involving reams of patient data, hundreds of documents and hours of...
Case Study: Successful In-Utero Aortic Valvuloplasty Reverses Heart Defects
Innovations in Cardiovascular Medicine and Surgery – Fall 2018 James Strainic, MD Ellie Ragsdale, MD Aimee K. Armstong, MD Introduction A routine prenatal scan of a 22-week-old fetus at University Hospitals MacDonald Women’s Hospital detected...